Avia Logo

Products /

emocha Health Medication Adherence Program

emocha Health Medication Adherence Program

emocha Health Medication Adherence Program

5 verified clientssign up to view


emocha Health Medication Adherence Program
emocha Health Medication Adherence Program



Select which hospital or health system you work at and see a personalized match score.

Support every patient at every dose.
Read more




Key Clients
Clients Your Size
0 People
5 Organizations
EHR integration


None provided

EMR Integration & Relevant Hardware:

None provided

EMRs Supported:

None provided

Hardware Compatibility:

None provided


emocha empowers patients to take every dose of medication through video technology and scalable human engagement. Patients use a smartphone application to report side effects, communicate with providers, and video record themselves taking medication at every dose. Providers or emocha’s clinician-led Adherence Solution team use a secure web portal to assess compliance adherence and engage with patients. The platform is being used by public health departments, hospitals, health centers, and managed care organizations across the globe to radically improve medication adherence for patients with diabetes, tuberculosis, opioid use disorder, asthma, COPD, hepatitis C, and other chronic and infectious diseases. Learn more at www.emocha.com.
Read more
Use cases

emocha works with patients who have chronic and infectious diseases, including tuberculosis, asthma, diabetes, substance use disorder, HIV, and hepatitis C.
Pediatric use cases:
emocha has most recently worked with pediatric asthma patients during a two-month program. During the program, patients used emocha to submit daily check-in videos of themselves taking their prescribed inhalers, while emocha’s care team provided daily and direct engagement to improve inhaler technique and adherence, and supported patients throughout treatment. emocha’s care team also delivered personalized engagement to help patients and families in maintaining their asthma care plans. Preliminary data suggests improved asthma control among participants, with a reduction in asthma-related ER visits and fewer oral steroid prescriptions. Outcomes included a high adoption rate among participants, with close to 1,000 virtual medication visits. Within the two-month program, the majority of patients exhibited at least one technique issue -- most of which were remotely handled by emocha’s clinical adherence team.

Differentiators vs EHR Functionality:

None provided

Differentiators vs Competitors:

None provided

Company information

Founded in 2010

14.9M total equity funding

Explore Related Resources